Okay, let's tackle this question about MEN 2B. The question is asking which of the options is not included in MEN 2B. First, I need to recall what MEN 2B includes. I remember that MEN 2 stands for Multiple Endocrine Neoplasia type 2. There are two subtypes: MEN 2A and MEN 2B.

MEN 2A typically includes medullary thyroid carcinoma, pheochromocytoma, and parathyroid hyperplasia or adenoma. MEN 2B is similar but has some differences. I think in MEN 2B, the parathyroid involvement is less common compared to 2A. Instead, there might be other features like mucosal neuromas, which are small growths on the lips and tongue, and a marfanoid body habitus. Also, there's a more aggressive form of medullary thyroid carcinoma in 2B.

So the question is which option is excluded. The options aren't provided here, but based on common distractors, the options might include things like pheochromocytoma, medullary thyroid carcinoma, parathyroid hyperplasia, and maybe something else. If the options include parathyroid hyperplasia as part of MEN 2B, that would be incorrect because MEN 2B usually doesn't have parathyroid issues. Instead, that's a feature of MEN 2A. So the answer would be the option that includes parathyroid hyperplasia as part of MEN 2B.

Let me verify. MEN 2B is associated with medullary thyroid carcinoma, pheochromocytoma, mucosal neuromas, and marfanoid features. Parathyroid hyperplasia is not a component of MEN 2B, which differentiates it from MEN 2A. So if one of the options is parathyroid hyperplasia, that's the correct answer here. The other options might include other features like medullary thyroid carcinoma, which is present in both, or pheochromocytoma, which is also present in both. Mucosal neuromas are specific to MEN 2B. So if the question is about what's excluded, the answer would be the option that lists parathyroid hyperplasia as part of MEN 2B.

**Core Concept**
Multiple Endocrine Neoplasia type 2B (MEN 2B) is a hereditary syndrome characterized by **medullary thyroid carcinoma (MTC)**, **pheochromocytoma**, and **mucosal neuromas**. It differs from MEN 2A by the absence of **hyperparathyroidism** and the presence of **marfanoid habitus**.

**Why the Correct Answer is Right**
MEN 2B is caused by mutations in the **RET proto-oncogene**, leading to uncontrolled proliferation of C-cells in the thyroid (MTC), adrenal medulla (pheochromocytoma), and neural crest-derived tissues (mucosal neuromas). Unlike MEN 2A, **parathyroid hyperplasia** is absent in MEN 2B. Instead, MEN 2A includes hyperparathyroidism as a key feature, distinguishing the two subtypes.

**Why Each Wrong Option is Incorrect

✓ Correct Answer: D. Primary hyperparathyroidism